tions (route c).5 In contrast, in THF and in the presence of
HMPA or DMPU, NCR anions undergo dearomatization
through anionic cyclization quantitatively.2,6
Table 1. Dearomatization-Electrophilic Quench of 5
The dearomatization-alkylation process of phosphina-
mides furnishes a variety of products, including γ-amino-
phosphinic acids, showing antitumor activity.6a,7,8 Extending
this methodology to phosphonamides will lead to amino-
phosphonic acids, important compounds due to their biologi-
cal properties.9 Lithiations directed by a phosphonamide
moiety have been limited to the ortho deprotonation of
PhP(X)(NMe2)2 (X ) O,10 S11).12
Fortuitously, in the reaction of the ortho-lithiated 2 with
benzonitrile, a dearomatized bicycle 4 was obtained (Scheme
2, 3). Heterocycle 4 is the only dearomatized product
Scheme 2. Directed Lithiation of Phenylphosphonamide
described for phosphonamides.13 We report here the first
dearomatizing anionic cyclization (DAC) of N-benzyl-P-
arylphosphonamides and the application of the method to
the synthesis of functionalized γ-aminophosphonic acids.
Preliminary evaluation of antitumor properties is also re-
ported.
The treatment of bis(N-benzyl-N-methyl)-P-phenylphos-
phonic diamide 514 with s-BuLi at -90 °C in THF followed
by electrophilic quench affords dearomatized products 8-10
in high yields (Table 1). Wide structural diversity is obtained
through the combined effect of the electrophile used and the
site of binding to the dearomatized anion.
a Isolated yield. b E+ ) MeOH. c Epimer at the phosphorus atom: 8%.
e
d Epimer at the phosphorus atom: 7%. E+ ) DTBMP. f Epimer at the
phosphorusatom:17%.g Epimeratthephosphorusatom:11%.h Diastereomeric
ratio at the hydroxilated carbon, S*:R* with respect to the phosphorus atom.
i Epimer at the phosphorus atom: 18%.
position and the anion generated, 6, attacks the ortho position
of the P-phenyl ring to give the dearomatized species 7.
Similar to phosphinamides,2,6 quenching the reaction with
MeOH introduces a proton at the R carbon with respect to
the phosphorus leading to 8a (entry 1), whereas protonation
with 2,6-di(tert-butyl)-4-methylphenol (DTBMP) and alky-
lation with benzyl bromide takes place almost exclusively
at the γ position providing 10a and 10b, respectively (entries
3-5). Two aspects of these transformations are worth
mentioning. First, the effect of DMPU on the efficiency of
the reaction is electrophile dependent. Yields of products
obtained by protonation with DTBMP or alkylation with
BnBr and benzophenone are higher in the presence of DMPU
(entries 3, 4, 5, and 10). For aldehydes and methanol as
electrophiles, the DAC reaction proceeds reasonably well
in the absence of strong coordinating cosolvent provided that
the metalation time is increased to 7 h.15 Second, small
amounts of the corresponding epimer at the phosphorus atom
The formation of compounds 8-10 implies that s-BuLi
deprotonates phosphonamide 5 selectively at the benzylic
(2) (a) Ferna´ndez, I.; Lo´pez-Ortiz, F.; Tejerina, B.; Garc´ıa-Granda, S.
Org. Lett. 2001, 3, 1339. (b) Ramallal, A.; Ferna´ndez, I.; Lo´pez-Ortiz, F.;
Gonza´lez, J. Chem. Eur. J. 2005, 11, 3022.
(3) Ferna´ndez, I.; On˜a-Burgos, P.; Ruiz-Go´mez, G.; Bled, C.; Garc´ıa-
Granda, S.; Lo´pez-Ortiz, F. Synlett 2007, 611.
(4) Ferna´ndez, I.; Lo´pez-Ortiz, F. Chem. Commun. 2004, 1142.
(5) On˜a-Burgos, P.; Ferna´ndez, I.; Iglesias, M. J.; Torre-Ferna´ndez, L.;
Garc´ıa-Granda, S.; Lo´pez-Ortiz, F. Org. Lett. 2008, 10, 537.
(6) (a) Ferna´ndez, I.; Lo´pez Ortiz, F.; Mene´ndez Vela´zquez, A.; Garc´ıa-
Granda, S. J. Org. Chem. 2002, 67, 3852. (b) Ruiz-Go´mez, G.; Lo´pez-
Ortiz, F. Synlett 2002, 781. (c) Ferna´ndez, I.; Force´n-Acebal, A.; Lo´pez-
Ortiz, F.; Garc´ıa-Granda, S. J. Org. Chem. 2003, 68, 4472. (d) Ferna´ndez,
´
I.; Ruiz-Go´mez, G.; Iglesias, M. J.; Lo´pez-Ortiz, F.; Alvarez-Manzaneda,
R. ArkiVoc 2005, 9, 375. (e) Ferna´ndez, I.; Ruiz-Go´mez, G.; Alfonso, I.;
Iglesias, M. J.; Lo´pez-Ortiz, F. Chem. Commun. 2005, 5408. (f) Ruiz-
Go´mez, G.; Iglesias, M. J.; Serrano-Ruiz, M.; Lo´pez-Ortiz, F. J. Org. Chem.
2007, 72, 9704.
(7) Ruiz-Go´mez, G.; Iglesias, M. J.; Serrano-Ruiz, M.; Garc´ıa-Granda,
S.; Francesch, A.; Lo´pez-Ortiz, F.; Cuevas, C. J. Org. Chem. 2007, 72,
3790.
(8) Lo´pez-Ortiz, F. ; Ferna´ndez, I. ; Ruiz-Go´mez, G. ; Yan˜ez-Rodr´ıguez,
V. PharmaMar S.A., PCT/WO, 2008/003809A1, 2008.
(9) (a) Kukhar, V. P., Hudson, H. R., Eds. Aminophosphonic and
Aminophosphinic Acids. Chemistry and Biological ActiVity; John Wiley:
New York, 2000. (b) Kafarski, P.; Lejczak, B. Curr. Med. Chem.-Anti-
Cancer Agents 2001, 1, 301. (c) Palacios, F.; Alonso, C.; De los Santos,
J. M. Chem. ReV. 2005, 105, 899.
(11) Craig, D. C.; Roberts, N. K.; Tanswell, J. L. Aust. J. Chem. 1990,
43, 1487.
(12) For NCa litiation-alkylation of P-alkylphosphonamidates, see: (a)
Afarinkia, K.; Jones, C. L.; Yu, H.-W. Synlett 2003, 509. (b) Pedrosa, R.;
Maestro, A.; Pe´rez-Encabo, A.; Raliegos, R. Synlett 2004, 1300. (c) Lo´pez,
B.; Maestro, A.; Pedrosa, R. Synthesis 2006, 817. (d) For ortho lithiation
of phosphonamidates, see: Vinci, D.; Mateus, N.; Wu, X.; Hancock, F.;
Steiner, A.; Xiao, J. Org. Lett. 2006, 8, 215.
(10) Dashan, L.; Trippett, S. Tetrahedron Lett. 1983, 24, 2039.
3982
Org. Lett., Vol. 10, No. 18, 2008